Delivery Order SPE2DB20D9214-SPE2DB25FD4TW

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,640.08 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,250.73 contract is for the delivery of 4,567,951,594 units of Atovaquone-Proguanil 250-100 100s, a prescription medication. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,067.00 and has a completion date of June 26, 2024. DMS Pharmaceutical Group will supply the DLA with 4564993076 units of Atovaquone-Proguanil 250-100mg tablets. This delivery order is issued under a larger indefinite delivery...
This federal contract award SPE2DX15D9903|SPE2DX24FASKZ was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,513.23 firm fixed-price delivery order is for the provision of 4564930044! ATOVAQUONE/PROGUANIL, a pharmaceutical product, with a completion date of May 23, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,342.16 firm fixed-price delivery order is for the supply of 4567941025 ! ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,390.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of ATOVAQUONE/PROGUANIL, a pharmaceutical product, and does not have a set-aside designation. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,396.19, is a delivery order under the Defense Logistics Agency (DLA) SPE2DX24FASMA program. The contract is for the delivery of ATOVAQUONE/PROGUANIL, a pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). The contract has a firm fixed-price pricing type and a completion date...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,111.76, is for the delivery of 4,568,118,586 units of Atovaquone-Proguanil 250-100 100S, a prescription medication. The contract has a period of performance through May 5, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $18,790.20 firm fixed-price delivery order contract is for the supply of Atovaquone-Proguanil 250-100 mg tablets, to support the medical needs of military health facilities. The award is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract that DMS Pharmaceutical Group holds with DLA,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,499.52 contract is for the delivery of 4558986658 - ATOVAQUONE-PROGUANIL 250-100 100S, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which covers a...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB25FD4TW
    Delivery Order

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,561.44, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the supply of Atovaquone-Proguanil 250-100 UD 24S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract has an ultimate completion date of April 8, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items.

Generated 7/7/25, 1:08 PM